Wright Bonilla Discusses Gene Patents
14 November 2010
BioCentury This Week
News
Foley Partner Jacqueline Wright Bonilla appeared in a video segment published to BioCentury This Week on November 14, 2010 titled "Myriad Pro-Con." Wright Bonilla clarifies the definition of gene patents and makes the case for a company’s right to commercialize research and development that could lead to a diagnostic in a drug. She also discusses the Assn. for Molecular Pathology, et al. v. USPTO, et al. (ACLU v. Myriad) "gene patenting" case.
Related Services
Practice Areas
Insights
The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) Is Enacted Into Law
27 March 2020
Coronavirus Resource Center
USTR Grants Section 301 Exclusions for Chinese-Origin Medical Supplies Needed in the Coronavirus Fight and Establishes Procedures for Seeking New Medical Exclusions
27 March 2020
Coronavirus Resource Center
Coronavirus Threats to Privacy!
27 March 2020
Internet, IT & e-Discovery Blog
SEC Focuses on Operational Continuity in Connection with Coronavirus (COVID-19)
27 March 2020
Coronavirus Resource Center
Foley Attorneys San Diego Super Lawyers
27 March 2020
Converse Quoted on Grim Outlook for M&A Work in Texas This Year
26 March 2020
Texas Lawbook
Ferrante Explains How the Rules of Telemedicine Have Changed Amid COVID-19 Pandemic
25 March 2020
The Hospital Finance Podcast
Overly Quoted in Digital Munition About Emergence of AI, Automation as Critical Tools for Cybersecurity
25 March 2020
Digital Munition
2020 AANP National Conference
23-28 June 2020
New Orleans, LA
gpTRAC 2020 – Telehealth Everywhere 2020 Conference
17-19 May 2020
Bloomington, MN
2020 NRTRC Conference
15-17 April 2020
WEBINAR: Responding to COVID-19 – Rapid Development and Launch Strategies for Diagnostics, Vaccines, and Therapeutics in a Global Pandemic
26 March 2020
Webinar